| 1 |
A2A receptor
(414 times)
|
Neurology
(82 times)
|
PD (28 times)
D2R (23 times)
GPCRs (23 times)
|
1999 Stimulation of expression for the adenosine A2A receptor gene by hypoxia in PC12 cells. A potential role in cell protection.
|
| 2 |
adenosine 2A receptor
(64 times)
|
Pharmacology
(8 times)
|
GPCR (4 times)
D2R (3 times)
EAU (3 times)
|
2004 Epoxyeicosatrienoic acids mediate adenosine-induced vasodilation in rat preglomerular microvessels (PGMV) via A2A receptors.
|
| 3 |
A2A adenosine receptor
(55 times)
|
Pharmacology
(9 times)
|
WT (4 times)
NK (3 times)
ADO (2 times)
|
1991 The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis.
|
| 4 |
A(2A) receptor
(7 times)
|
Neurology
(4 times)
|
A1R (2 times)
BP (2 times)
PET (2 times)
|
2004 The adenosine A1 receptor contributes to the stimulatory, but not the inhibitory effect of caffeine on locomotion: a study in mice lacking adenosine A1 and/or A2A receptors.
|
| 5 |
A2AR-tag mice
(2 times)
|
Neuroanatomy
(1 time)
|
---
|
2022 Genetic tagging of the adenosine A2A receptor reveals its heterogeneous expression in brain regions.
|
| 6 |
A2-adenosine receptor binding subunits
(1 time)
|
Molecular Biology
(1 time)
|
---
|
1990 Glycoprotein nature of the A2-adenosine receptor binding subunit.
|
| 7 |
A2A adenosine receptor subtype
(1 time)
|
Neurology
(1 time)
|
---
|
2017 Cognitive impairments associated with alterations in synaptic proteins induced by the genetic loss of adenosine A2A receptors in mice.
|
| 8 |
A2A subtype of adenosine receptor
(1 time)
|
Neurology
(1 time)
|
A2A KO (1 time)
CNS (1 time)
MPTP (1 time)
|
2016 Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.
|
| 9 |
adenosineA2A adenosine receptor
(1 time)
|
Medicine
(1 time)
|
ARDS (1 time)
|
2020 Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia.
|
| 10 |
hypoxia-A2A adenosine receptors
(1 time)
|
Neoplasms
(1 time)
|
HBOC (1 time)
TME (1 time)
TNBC (1 time)
|
2022 The anti-tumoral effects of the oxygen carrier YQ23 in a triple-negative breast cancer syngeneic model.
|
A Search Service for Abbreviation / Long Form